19785Toplam
50Olumlu
0Olumsuz
0Nötr
Piyasa:
Tümü
🇹🇷 BIST
Kripto
🇺🇸 ABD
🇰🇿 KASE
🇪🇬 EGX
🇸🇾 DSE
🇸🇦 Tadawul
🇦🇪 DFM
🇶🇦 QSE
🇷🇺 MOEX
🇬🇧 LSE
🇩🇪 Xetra
🇪🇺 Euronext
🇸🇪 Nordic
🇲🇦 CSE
🇯🇴 ASE
BRVM
🇮🇳 India
🇭🇰 HKEX
🇰🇷 KRX
🇿🇦 JSE
🇦🇺 ASX
🇧🇷 B3
🇹🇼 TWSE
🇸🇬 SGX
🇨🇳 China
🇯🇵 Japan
Sayfa 16 / 396 · toplam 19785 haber
▲
European shares rise on lower oil prices, bank strength ahead of earnings - Reuters
Bu özet yapay zekâ ile otomatik üretildi
European shares rise on lower oil prices, bank strength ahead of earnings Reuters
▲
Canara Robeco Q2 FY27 slides: profit surges 22% amid AUM pressures
Bu özet yapay zekâ ile otomatik üretildi
Canara Robeco Q2 FY27 slides: profit surges 22% amid AUM pressures
▲
India's monthly fund investments hit record highs despite market slide - Reuters
Bu özet yapay zekâ ile otomatik üretildi
India's monthly fund investments hit record highs despite market slide Reuters
▲
IMF chief says AI boom supports 3% global growth and lifts Asia’s outlook
Bu özet yapay zekâ ile otomatik üretildi
IMF chief says AI boom supports 3% global growth and lifts Asia’s outlook
▲
Asian markets mixed following Wall Street gains; heavy earnings week ahead
Bu özet yapay zekâ ile otomatik üretildi
Asian markets mixed following Wall Street gains; heavy earnings week ahead
▲
Asbis Veri Merkezleri ve Yapay Zekaya Odaklanıyor
Bu özet yapay zekâ ile otomatik üretildi
Varşova'da işlem gören Asbis, %476'lık hisse rallisini sürdürmek için veri merkezleri ve yapay zekaya odaklanıyor.
▲
Indian rupee surges after RBI unveils measures to support currency
Bu özet yapay zekâ ile otomatik üretildi
Indian rupee surges after RBI unveils measures to support currency
▲
Copper Gains on Easing Rate-Hike Bets and Chile Mine Avalanche - Bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
Copper Gains on Easing Rate-Hike Bets and Chile Mine Avalanche Bloomberg.com
▲
IMF says AI investment keeps global growth around 3%, with major Asia benefits
Bu özet yapay zekâ ile otomatik üretildi
IMF says AI investment keeps global growth around 3%, with major Asia benefits
▲
2 Unstoppable Cryptocurrencies Poised for Massive Gains This Year
Bu özet yapay zekâ ile otomatik üretildi
These two projects are big and innovative twists on concepts that previously existed in crypto.
▲
RBI's rupee boost to spur rally, trigger swings in forward premiums - Reuters
Bu özet yapay zekâ ile otomatik üretildi
RBI's rupee boost to spur rally, trigger swings in forward premiums Reuters
▲
3 Tech Stocks Wall Street Upgraded Last Week, and the One I'd Buy First
Bu özet yapay zekâ ile otomatik üretildi
Microsoft, Palantir, and Marvell all got upgrades last week -- but Marvell is the one I'd pick.
▲
TSMC expected to report sixth straight quarter of record profit thanks to AI boom
Bu özet yapay zekâ ile otomatik üretildi
TSMC expected to report sixth straight quarter of record profit thanks to AI boom
▲
Microsoft Needs Azure to Keep Growing Faster Than 40% When It Reports on Oct. 28
Bu özet yapay zekâ ile otomatik üretildi
The stock is within 2% of its record close.
▲
Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?
Bu özet yapay zekâ ile otomatik üretildi
IBB has delivered stronger returns than IYH but with dramatically sharper swings in both directions.
▲
Forget Chasing Volume. Here's the Most Active Stock I'd Actually Hold for 5 Years.
Bu özet yapay zekâ ile otomatik üretildi
Microsoft stands out as a strong five-year hold because of its growing Azure and AI businesses, massive cash generation, and diversified business.
▲
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH?
Bu özet yapay zekâ ile otomatik üretildi
VanEck offers lower costs and higher dividends with a concentrated pharma focus, while Simplify provides broader healthcare exposure and donates profits to breast cancer research.
▲
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap - Bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap Bloomberg.com
▲
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?
Bu özet yapay zekâ ile otomatik üretildi
One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.
▲
History Says This Will Happen to AMD Stock in 2027
Bu özet yapay zekâ ile otomatik üretildi
The chipmaker has had a great year, but its stock has risen too far, too fast.
▲
Forget the Recent Delivery Beat: Here's the Key Number That Will Decide Investors' Reaction to Tesla's Earnings
Bu özet yapay zekâ ile otomatik üretildi
Tesla's third-quarter deliveries were impressive, but investors will focus on gross margin when full results come out.
▲
Amazon and Alphabet Just Committed $420 Billion to Data Centers. 1 Stock Is the Better Buy.
Bu özet yapay zekâ ile otomatik üretildi
Each company stands to benefit from booming cloud growth in its own way.
▲
Starknet coin surges as developer weighs Ethereum split over quantum security
Bu özet yapay zekâ ile otomatik üretildi
Starknet coin surges as developer weighs Ethereum split over quantum security
▲
Banco Bradesco Wealth Management Chief Purchases $1.1 Million Preference Shares. Is This Brazilian Financial Powerhouse Stock a Buy?
Bu özet yapay zekâ ile otomatik üretildi
Jose Augusto Ramalho Miranda bought at $17.98 per share, a significant premium to current market levels, signaling strong conviction in the bank's value.
▲
How to Beat a Choppy Market With 4 Steady Stocks
Bu özet yapay zekâ ile otomatik üretildi
These companies have proven to be safe havens during choppier markets.
▲
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
Bu özet yapay zekâ ile otomatik üretildi
Analysts see another big year in the stock market.
▲
Axon Enterprise vs. Turning Point Brands: Which Slumping Stock Is a Better Rebound Candidate Right Now?
Bu özet yapay zekâ ile otomatik üretildi
One invests in growth through public safety tech; the other generates steady cash from iconic consumer brands.
▲
Qualcomm Doesn't Look Cheap Next to Its AI Chip Peers. Here's Why.
Bu özet yapay zekâ ile otomatik üretildi
The mobile chipmaker is struggling to keep up with its higher-growth peers.
▲
EU plans yearly cap of 350,000 Chinese hybrid cars as trade tensions rise
Bu özet yapay zekâ ile otomatik üretildi
EU plans yearly cap of 350,000 Chinese hybrid cars as trade tensions rise
▲
3 Reasons Rocket Lab Stock Could Double in 2027 -- and 1 Reason It Might Not
Bu özet yapay zekâ ile otomatik üretildi
Defense deals, a blockbuster new rocket, and record revenue: Here are what could power this space stock toward a monster 2027.
▲
Volkswagen CEO urges EU support for turnaround as Chinese rivals gain ground
Bu özet yapay zekâ ile otomatik üretildi
Volkswagen CEO urges EU support for turnaround as Chinese rivals gain ground
▲
5 Decades of Data Confirm Long-Term Dividend Investing Delivers Real Returns
Bu özet yapay zekâ ile otomatik üretildi
Fifty years of market data says the same thing every time someone checks it: Dividend growers quietly beat the market with less drama along the way.
▲
Prediction: My Top 2 Stocks to Buy Now Will Outperform the Stock Market Over the Next Decade
Bu özet yapay zekâ ile otomatik üretildi
These elite businesses could help you build lasting wealth.
▲
EOS Climbs 11% As Investors Gain Confidence
Bu özet yapay zekâ ile otomatik üretildi
EOS Climbs 11% As Investors Gain Confidence
▲
Bank earnings, CPI headline busy markets week as S&P 500 hovers near records
Bu özet yapay zekâ ile otomatik üretildi
Bank earnings, CPI headline busy markets week as S&P 500 hovers near records
▲
Why ’Net Stocks’ are down sharply this year despite Nasdaq’s gains
Bu özet yapay zekâ ile otomatik üretildi
Why ’Net Stocks’ are down sharply this year despite Nasdaq’s gains
▲
Here's Where These 4 Nuclear Reactor Stocks Could Be in 5 Years
Bu özet yapay zekâ ile otomatik üretildi
Four nuclear reactor stocks could look very different by 2031, as progress in reactors, revenue growth, and valuations determine shareholder returns.
▲
SpaceX vs. Micron: Which Is the Better Artificial Intelligence (AI) Stock to Own for the Next 5 Years?
Bu özet yapay zekâ ile otomatik üretildi
SpaceX looks poised to outperform Micron in the coming years.
▲
This Nvidia Partner Was My Top Pick for 2026, and It's Up 43%: Here's Why It's Still a Great Value Now
Bu özet yapay zekâ ile otomatik üretildi
This company is positioned for medium-term and long-term growth in the AI market.
▲
How InvestingPro spotted Hanmi Financial’s 67% gain in January 2024
Bu özet yapay zekâ ile otomatik üretildi
How InvestingPro spotted Hanmi Financial’s 67% gain in January 2024
▲
Prediction: Netflix Stock Is Going to Soar After Oct. 20
Bu özet yapay zekâ ile otomatik üretildi
Netflix stock looks incredibly cheap heading into its third-quarter earnings report.
▲
3 Surging Cryptocurrencies to Buy Now and Hold for 5 Years or More
Bu özet yapay zekâ ile otomatik üretildi
These three coins are positioned to be valuable crypto infrastructure, and they're all gaining traction.
▲
Prediction: This Is How Much Micron Stock Will Be Worth By the End of 2027
Bu özet yapay zekâ ile otomatik üretildi
Micron has already surged 1,100% in a year and a half.
▲
Costco Stock Is 14% Below Its Record. History Says Buyers Have Usually Been Rewarded.
Bu özet yapay zekâ ile otomatik üretildi
Past dips in the warehouse club's shares have mostly paid off.
▲
Uber exits four African markets as cheaper rivals gain ground - Bloomberg
Bu özet yapay zekâ ile otomatik üretildi
Uber exits four African markets as cheaper rivals gain ground - Bloomberg
▲
Musk vows affordable Starlink in India days before Ambani’s record Jio IPO
Bu özet yapay zekâ ile otomatik üretildi
Musk vows affordable Starlink in India days before Ambani’s record Jio IPO
▲
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens
Bu özet yapay zekâ ile otomatik üretildi
PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.
▲
Should Investors Buy Navitas Semiconductor Stock on the Dip?
Bu özet yapay zekâ ile otomatik üretildi
The business is on the cusp of accelerating revenue growth.
▲
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
Bu özet yapay zekâ ile otomatik üretildi
After a few years of stagnation, this stock is soaring.
▲
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Canopy pursues a lean U.S.-focused strategy while Tilray has diversified into beverages, but their diverging paths and financial profiles reveal starkly different risk-reward profiles for 2026.
Sayfa 16 / 396 · toplam 19785 haber